Long-term effectiveness and safety of transcatheter closure of patent foramen ovale compared with antithrombotic therapy alone: a meta-analysis of six randomised clinical trials and 3,560 patients with reconstructed time-to-event data
Authors:
- Nicola CaronnaNCNicola Caronna
- Antonio H. FrangiehAFAntonio H. Frangieh
- Jonathan MichelJMJonathan Michel
- Giuseppe AndòGAGiuseppe Andò
- Giuseppe TarantiniGTGiuseppe Tarantini
- Albert M. KaselAKAlbert M. Kasel
- Davide CapodannoDCDavide Capodanno
- Robert A. ByrneRBRobert A. Byrne
- 1 October 2018
- journal article
- research article
- Published by Europa Digital & Publishing in EuroIntervention
- Vol. 14 (8) , 857-867
Abstract
The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)Keywords
This publication has 44 references indexed in Scilit:
- Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curvesBMC Medical Research Methodology, 2012
- Tools & Techniques: PFO/ASD closureEuroIntervention, 2011
- Randomized clinical trial comparing percutaneous closure of patent foramen ovale (PFO) using the Amplatzer PFO Occluder with medical treatment in patients with cryptogenic embolism (PC-Trial): rationale and designTrials, 2011
- Study Design of the CLOSURE I TrialStroke, 2010
- Patent Foramen Ovale: Current Pathology, Pathophysiology, and Clinical StatusJACC, 2005
- What to add to nothing? Use and avoidance of continuity corrections in meta‐analysis of sparse dataStatistics in Medicine, 2004
- Measuring inconsistency in meta-analysesBMJ, 2003
- Proportional hazards tests and diagnostics based on weighted residualsBiometrika, 1994
- Prevalence of Patent Foramen Ovale in Patients with StrokeNew England Journal of Medicine, 1988
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958